Finance

Lists
AIDX:NASDAQ
20/20 Biolabs Inc
$0.52
-6.51%
(-0.036) 1D
$0.52
-0.04% (-0.00020)
After hours
Closed: Aug 24, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AIDX...
Open
$0.56
High
$0.56
Low
$0.51
Mkt. cap
6.67M
Avg. vol.
115.44K
Volume
0.00
52-wk high
$50.00
52-wk low
$0.40
EPS
-$1.04
No. of employees
9
Open
$0.56
High
$0.56
Low
$0.51
Mkt. cap
6.67M
Avg. vol.
115.44K
Volume
0.00
52-wk high
$50.00
52-wk low
$0.40
EPS
-$1.04
No. of employees
9
About 20/20 Biolabs Inc
CEO-
Employees9
Founded2000
HeadquartersRockville, Maryland, United States
SectorMedical device
Website2020biolabs.com
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Buy
Maintained
$5.00
+864.9%
05/21/2026
Brian Kinstlinger
Alliance Global Partners
Buy
Maintained
CA$2.00
+286%
05/08/2026
Justin Keywood
Stifel Nicolaus
Buy
Maintained
CA$2.50
+382.4%
03/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
417.98K
538.27K
353.38K
730.57K
Cost of goods sold
272.91K
407.86K
290.49K
425.84K
Cost of revenue
272.91K
407.86K
290.49K
425.84K
Research and development expenses
131.06K
130.55K
153.48K
257.63K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
814.18K
912.71K
1.35M
1.29M
Operating expense
945.24K
1.04M
1.51M
1.55M
Total operating expenses
1.22M
1.45M
1.80M
1.97M
Operating income
-800.17K
-912.85K
-1.44M
-1.24M
Other non operating income
-
-273.03K
-471.12K
-4.35K
EBT including unusual items
-825.54K
-1.31M
-2.17M
-1.51M
EBT excluding unusual items
-825.54K
-1.31M
-2.17M
-1.51M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-825.54K
-1.31M
-2.17M
-1.51M
Net profit margin
-197.51%
-242.96%
-615.45%
-206.19%
Earnings per share
-
-
-
-
Interest and investment income
4.18K
3.09K
6.65K
14.48K
Interest expense
-29.55K
-124.98K
-267.01K
-272.24K
Net interest expenses
-25.37K
-121.90K
-260.36K
-257.77K
Depreciation and amortization charges
-
-
-
-
EBITDA
-779.11K
-892.71K
-1.43M
-1.22M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps